Zimmer Biomet Holdings Inc [ZBH] stock is trading at $113.18, up 0.82%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZBH shares have gain 1.74% over the last week, with a monthly amount glided 8.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on December 17, 2024, when JP Morgan upgraded its rating to a Overweight and also boosted its price target to $128 from $125. On July 01, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $115 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $129 on May 30, 2024. Argus upgraded its rating to a Buy but $150 remained the price target by the analyst firm on May 21, 2024. Evercore ISI downgraded its rating to In-line for this stock on January 04, 2024, and downed its price target to $125. In a note dated October 20, 2023, ROTH MKM initiated an Neutral rating and provided a target price of $120 on this stock.
Zimmer Biomet Holdings Inc [ZBH] stock has fluctuated between $97.69 and $131.61 over the past year. Currently, Wall Street analysts expect the stock to reach $122 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $113.18 at the most recent close of the market. An investor can expect a potential return of 7.79% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 7.68B for the trailing twelve months, which represents a growth of 4.28%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 111.82 points at the first support level, and at 110.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 114.09, and for the 2nd resistance point, it is at 114.99.
Ratios To Look Out For
For context, Zimmer Biomet Holdings Inc’s Current Ratio is 1.91. Also, the Quick Ratio is 0.99, while the Cash Ratio stands at 0.33. Considering the valuation of this stock, the price to sales ratio is 2.93, the price to book ratio is 1.81 and price to earnings (TTM) ratio is 25.51.
Transactions by insiders
Recent insider trading involved Winkler Lori, SVP and CHRO, that happened on Mar 05 ’25 when 1443.0 shares were sold. Officer, Winkler Lori completed a deal on Mar 05 ’25 to buy 1443.0 shares. Meanwhile, Group President, Asia Pacific Yi Sang sold 12857.0 shares on May 31 ’24.
